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Abstract: Phytoplankton is acknowledged to be a very diverse source of bioactive 
molecules. These compounds play physiological roles that allow cells to deal with changes 
of the environmental constrains. For example, the diversity of light harvesting pigments 
allows efficient photosynthesis at different depths in the seawater column. Identically, lipid 
composition of cell membranes can vary according to environmental factors. This, together 
with the heterogenous evolutionary origin of taxa, makes the chemical diversity of 
phytoplankton compounds much larger than in terrestrial plants. This contribution is 
dedicated to pigments and lipids synthesized within or from plastids/photosynthetic 
membranes. It starts with a short review of cyanobacteria and microalgae phylogeny. Then 
the bioactivity of pigments and lipids (anti-oxidant, anti-inflammatory, anti-mutagenic,  
anti-cancer, anti-obesity, anti-allergic activities, and cardio- neuro-, hepato- and 
photoprotective effects), alone or in combination, is detailed. To increase the cellular 
production of bioactive compounds, specific culture conditions may be applied (e.g., high 
light intensity, nitrogen starvation). Regardless of the progress made in blue biotechnologies, 
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the production of bioactive compounds is still limited. However, some examples of large 
scale production are given, and perspectives are suggested in the final section. 
Keywords: plastids; carotenoids; cyanobacteria; microalgae; polyunsaturated fatty  
acids; tetrapyrroles 
 
1. Introduction 
Phytoplankton was coined in 1897 using the Greek words φυτόν (phyton), meaning “plant”, and 
πλαγκτός (planktos), meaning “wanderer” or “drifter” [1]. Phytoplankton is therefore a generic term 
designing unicellular prokaryotic and eukaryotic organisms. Most of the taxa are autotrophic but taxa 
such as Polytoma sp., Polytomella sp., Prototheca wickerhamii, etc., have been described with 
degenerated chloroplasts [2,3]. These taxa grow heterotrophically in the dark whereas other algae 
ordinarily grow phototrophically in the light. Despite the fact that the number of newly described 
species is increasing yearly [4–6] only a small percentage of species belonging to phytoplankton have 
been described so far [7]. Phytoplankton has colonized every type of ecological niche, and it 
constitutes the dominant group of living organisms in term of species diversity in marine waters [8]. 
Phytoplankton was playing crucial roles during Earth evolution. For instance, cyanobacteria were at 
the origin of the rise of the atmospheric oxygen, an event known as the Great Oxidation Event  
(GOE) [9–11]. Today, the contribution of phytoplankton to the biosphere continues to be unique 
because this group largely contributes to the renewal of the atmospheric oxygen and acts as a 
tremendous sink for CO2, which is used for the synthesis of organic compounds through 
photosynthesis [12]. This function makes phytoplankton crucial primary producers on which every 
food chain relies. While accounting for less than 1% of Earth’s biomass, phytoplankton is responsible 
for more than 50% annual net biomass production [13,14]. It is known for ages that marine organisms, 
including phytoplankton, constitute a pretty diversified source of compounds interesting for health, 
well-being, cosmetics, new fuels etc. [7,15–18]. Actually, it is estimated that approximately  
20,000 active substances originating from marine organisms are used in the industry and can be used 
as an alternative source of chemically synthesized medicine [19]. As mentioned earlier, phytoplankton 
differentiates from other planktonic taxa by the presence of photosynthetic membranes. In prokaryotic 
species, the photosynthetic membranes are located within the cytosol whereas in eukaryotic species, 
they are enclosed in a cell compartment denoted as the chloroplast (for a review, see [20]). Beside the 
photosynthetic activity, chloroplasts are involved in many biosynthetic pathways and constitute as 
much as real cellular factories synthesizing crucial cell components such as lipids and pigments [21]. 
This manuscript starts with reminders on plastid phyllogeny. Then two families of compounds are 
considered, i.e., pigments and lipids; their diversity is described and their health benefits are detailled. 
Tetrapyrroles and carotenoids have strong anti-oxidant, anti-inflammatory and anti-mutagenetic 
activities, whereas lipids (essentially polyunsaturated fatty acids) have anti-cholesterol and 
cardioprotective effects. The following section deals with the cellular increased production of the 
bioactive molecules by variation of environmental parameters. Because plastids derived from 
photosynthetic prokaryotes, cyanobacteria have been also considered in this review. 
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2. Plastid Phylogeny 
According to the fossil record cyanobacteria were already present over 2 billion years ago [22]. 
Based on the assumption that cyanobacteria were responsible of the GOE, it is thought that this 
phylum existed already 2.45–2.32 Bya [9–11]. The impact of GOE cannot be emphasized enough as 
this event changed Earth’s history by enabling the evolution of aerobic life [23]. Oxygen accumulation 
in the atmosphere was the result of oxygenic photosynthesis. This process required four 
macrocomplexes, namely the water-oxidizing photosystem II (PSII), cytochrome b6/f, photosystem I 
(PSI), and the H+-translocating ATP synthetase (CF0F1) [24]. They supply ATP and NADPH for 
synthesis of many essential compounds for autotrophic growth and the synthesis of many compounds 
including those discussed in this contribution. 
A photosystem is a pigment-protein complex composed of a reaction center (RC) and  
a light-harvesting complex (LHC). Two families of pigments are found in LHCs: the tetrapyrroles and 
carotenoids [25,26]. Besides the typical closed tetrapyrrole chlorophyll (Chl) a and β-carotene, 
cyanobacteria harbour usually two types of accessory pigments, i.e., open tetrapyrroles (phycobilins) 
and glycosylated xanthophylls [27]. Phycobilins (PBS) are also accessory pigments in red algae and 
Glaucophytes. In the other eukaryotic phytoplanktonic taxa, Chla a is accompanied by another type of 
Chl (Table 1). Chlorophyllin (Chlin) is a water-soluble semi-synthetic derivative of Chl that is widely 
used as a food colorant, and is commercially available as an herbal “remedy”. Therefore, although not 
natural, this compound was also considered in this review. 
On the basis of molecular, biochemical and cellular arguments, it is classically assumed that 
eukaryotic phytoplankton derives from the internalization of a cyanobacterium-type organism into a 
eukaryotic heterotrophic cell, the so-called first endosymbiotic act (for a review, see [28]). The 
reconstitution of true phylogenetic history of organisms has become a very important issue in biology. 
The availability of numerous molecular sequences allowed biologists to propose new hypotheses for 
evolutionary histories of taxa that lead eventually to unresolved or conflicting interpretations and the 
real history seems more complicated than thought initially (see for instance [29–31]) and will not be 
discussed here. This primary endosymbiotic act explains why today’s chloroplasts have two envelopes 
(for a review on the photosynthetic membranes in phytoplankton, see [20]). To explain the presence of 
additional membranes around the chloroplasts, additional endosymbiotic acts are invoked [32], for a 
review, see [33]. Actually, the recent phylogenetic studies carried out indicated that the history of 
secondary endosymbionts is more complicated than originally thought because a detailed study of the 
diatom genes support a putative green algal origin of several genes [14,20,30–34]. The members of the 
red lineage of secondary endosymbionts constitute a most diverse group of organisms. In these 
organisms, the gene mixing that occurred along evolution allowed a tremendous diversification of the 
metabolism and the most important from the pharmaceutical point of view being the diatoms 
(Heterokonta) and the dinoflagellates (Alveolata). 
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Table 1. Main chlorophyll and carotenoid types in the various taxa of photosynthetic organisms. “+” and “-” mean that the pigment was 
detected or not in the taxa. 
Pigment type Cyanobacteria Glaucophytes Red algae Brown algae Diatoms Green algae Land plants 
PBS + + + - - - - 
Chl a 
+, except in Acaryochloris marina 
and related taxa 
+ + + + + + 
Chl b except in Prochlorophytes - - - - + + 
Chl c - - - + + - - 
Chl d 
Only in Acaryochloris marina and 
related taxa 
- - - - - - 
Chl f 
Only in filamentous cyanobacteria 
from stromatolites 
- - - - - - 
β-Carotene + + Unicellular + + + + 
Fucoxanthin - - - + + - - 
Diadinoxanthin - - - Traces + - - 
Diatoxanthin - - - Traces + - - 
Violaxanthin - - + + + + + 
Lutein Depends on species  Macrophytes - - + + 
Zeaxanthin Depends on species + + + Traces + + 
Xanthophyll cycle - - - + + + + 
Echinenone Depends on species - Traces Traces -  Adonis sp. 
Myxoxanthophyll Depends on species - - - - - - 
Canthaxanthin Anabaena - - - - 
Depen on 
species 
Adonis sp. 
Aphanizophyll Depends on species - - - - - - 
β-Cryptoxanthin Aphanizomenon - + - - + + 
Lycopene Nostoc - - - - 
Depend on 
species 
+ 
Synechoxanthin Synechococcus - - - - - - 
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3. Bioactivity of Pigments and Lipids from Plastids of Marine Phytoplankton 
As mentioned earlier, most of phytoplanktonic species are photoautotrophs. Consequently, they are 
rich in pigments. Three major classes of photosynthetic pigments are recognized, i.e., (1) Chls and  
Chl-related molecules, (2) Cars (carotenes and xanthophylls) and (3) PBS. Altogether the pigment 
family represents several hundreds of purified molecules [25,35]. All these molecules share the unique 
property to absorb light thanks to their characteristic conjugated double bond network [25,36,37]. 
Considering the high structural diversity of pigments and the possibility to chemically modify these 
molecules to obtain better pharmacological properties, the potential of phytoplankton as a source of 
molecules of therapeutical interest is obviously very high. Unfortunately, the lability and difficult 
purification of these molecules make the biological activity of most of these molecules unstudied. 
However, when purified pigments were obtained, they presented a high activity on pharmacological 
and cellular effectors even at very low concentrations. These molecules can therefore be used  
for chemoprevention. 
The superiority of marine molecules, as compared to analogue terrestrial resources, can be 
explained by the simultaneous presence of a wider variety of substances in marine organisms. These 
substances would act synergentically, providing an enhanced bioactivity [38]. Very often, synergistic 
actions between pigments and lipids are described. For instance, Rao & Rao [39] and Micallef &  
Garg [40] found a synergistic action between pigments, fatty acids and phytosterols on plasma lipid 
concentration decrease, on inflammatory response and thus on cardiovascular disease risk prevention. 
3.1. Pigments 
3.1.1. Tetrapyrroles 
Human populations regularly have been consuming green vegetables since the discovery of 
agriculture practices regularly some 15,000 years ago. This traditional and long practice made in the 
collective unconscious green pigments as save compounds. Indeed, Chl derivatives such as pheophytin 
have been found in some plants known in traditional medicine to be active against diseases such as 
Clinacanthus nutans-herpes simplex virus [41] and Lonicar hypoglauca-hepatitis C virus [42]. Until 
recently, almost nothing was known about the assimilation of closed tetrapyrroles: it was simply 
thought that Chl absorption was limited (1%–3%). Actually, the phytol chain of the native Chl 
molecules would be cleaved whereas the Mg ion is leached upon ingestion, the resulting pheophorbide 
and pheophytine being excreted in the feces [43]. Major progress in studying tetrapyrrole assimilation 
was possible when intestinal cell could be grown in vitro. Using such a model, i.e., Caco-2 human 
cells, [44] demonstrated that pheophytin can be absorbed as well. The anti-genotoxicity of natural Chls 
was revealed by Negishi et al. [45] whereas others studies reported the anti-oxidant activity, the 
modulation of xenobiotic enzyme activity, and the induction of apoptotic event in cancer cells of  
Chl [46,47]. This anti-cytotoxicity seems specific to natural Chl and could not be demonstrated with 
non-natural Chl molecules (see below) [48]. Chl precursors, Chl derivatives, or Chl analogs are also 
used in medicine for photodynamic treatments of cancers, e.g., [49]. 
The harmlessness of tetrapyrroles, especially Chl does not mean that the ingestion of tetrapyrroles 
is without danger. For instance, Chl intolerance can occur due to the liberation of the Chl phytol moity 
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in patients suffering from Refsum’s disease. In this pathology, phytanic acid accumulates in serum and 
other tissues due to a defect of the metabolic pathway for phytanic acid [43]. Lohrey et al. [50] 
demonstrated that albino rats fed with lucerne—but not with ryegrass—protein concentrate, develop 
photosensitization. This allergy to sunlight could be due to the accumulation of pheophorbide and 
related pigments in tissues [51]. Similar sunlight allergic reactions were reported in humans having 
ingested dried laver enriched with pheophorbides and pyropheophorbides [52]. Gandul-Rojas et al. [53] 
have shown that these deesterified tetrapyrroles are more strongly absorbed than the phytylated ones 
from the food matrix by the intestinal epithelial cells, allowing a larger accumulation in the patient 
body. Therefore, there is a need for information on the effects of processes on tetrapyrrole 
bioaccessibility and bioavailability. For instance, conservation industrial processes such as freezing 
and canning along with cooking have a positive effect on Chl bioavailability [54,55], making the 
pigment’s quantity after processing exceeding 100% of the value measured before processing  
(e.g., [56,57]). Non-natural Chls, such as Cu-Chls, Cu-pheophorbide, Cu-pheophytin, or Chlins, are 
digested similarly to natural Chl molecules, that is, the phytol chain is cleaved but the Cu ion is not 
leached from the porphyrin ring because the chelate is much more stable. The stability is only relative 
because an increase in Cu has been measured in the plasma following Chlin ingestion [58]. Several 
tests suggested that oral or parenteral administration of Chlins did not produce any gross adverse effect 
on health [59,60]. 
Phytoplankton contains also other types but usually minor tetrapyrroles such as hemes.  
Heme-protein complexes are degraded in the lumen of the stomach and small intestine [61]. Hemes 
being soluble in alkaline environment, they do not need to bind proteins for the luminal absorption, 
which is indeed facilitated by the presence of specific heme transporters such as the heme carrier 
protein 1 (HCP1) at the apical surface of enterocytes [62]. Once in the erythrocytes, hemes are cleaved 
by heme oxygenases yielding to iron, biliverdin and carbone monoxide formation [63]. Iron is driven 
to a labile iron pool and used for metabolism. Open tetrapyrroles derived from hemes through the 
oxygenation of the tetrapyrrole ring [64]. 
3.1.1.1. Anti-Oxidant, Anti-Inflammatory and Anti-Mutagenic Activities 
Many diseases such as cancer, diabetes and, neurodegenerative and cardiovascular diseases have  
in common oxidative stress as a major cause of inflammatory events. The anti-oxidant and  
anti-inflammatory activities of phytoplanktonic pigments are widely demonstrated and evidenced in 
numerous in vitro free and in vivo radical scavenging assays. The presence of a metal-chelate strongly 
enhances the anti-radical capacity closed tetrapyrroles. Protoporphyrin methyl ester and its magnesium 
chelated derivative, as well as pheophorbide b and pheophytin b, were also identified as strong  
anti-oxidant molecules [65]. The ability of the porphyrin ring to transfer electrons explains the  
anti-oxidant activity of Chls and derivatives. The highest anti-oxidant activity was obtained with of 
pheophorbide b, compared to pheophorbide a, suggesting that the presence of the aldehyde function 
may be critical to this activity [47]. This was confirmed in a study that investigated the action 
mechanisms of natural and synthetic porphyrins regarding their anti-inflammatory effects in vitro and 
in vivo [66]. Unfortunately, no structure related to the Chl familly of compounds has been tested 
leaving uncertain the effects of plant pigments on porphyrins targets such as the tumor necrosis factor 
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alpha production, the Fyn tyrosine kinase inhibitors [66]. However, on the basis of the study, some 
potential for Chl and Chl-derivatives can be hypothesized. More generally, it should be recall that the 
antioxidant properties of Chls and Chl-derivatives disappear in the presence of light. Actually, the 
accumulation of free tetrapyrroles in photosynthetic cells leads to a dramatic oxidative stress upon 
light illumination [67–69]. Metal-free and metallo-Chl derivatives have also anti-mutagenic activities, 
as demonstrated using a bacterial mutagenesis assay [47,70]. Similar properties are exhibited by  
open-chain tetrapyrroles (anti-oxidative: allophycocyanin [71], phycocyanin [72], phycoerythrin [73] 
and anti-inflammatory: phycocyanin [74]) in vitro. As a conclusion, most microalgal pigments exert 
strong in vitro anti-oxidant activity, but additional intervention trials are required to precise their 
absorption, metabolism and potential as natural anti-oxidant, anti-inflammatory and anti-mutagenic 
compounds in vivo. Very importantly, the capacity of phycocyanin to quench oxygen radical species is 
preserved in food supplement [75]. 
3.1.1.2. Anti-Cancer 
Chlin has been reported to have potent anti-mutagenic and anti-carcinogenic effects in short-term 
tests in vitro and in vivo [45,46]. There is an abundant literature about the interest of food molecules to 
preserve health, for reviews see [76]. However, it may happen that food, for instance stored in poor 
conditions, gets infected by molds such as Aspergillus flavus and A. parasiticus. These fungi secrete 
mycotoxin aflatoxin B1 (AFB), one of the most known human carcinogenesis linked to diet. The 
action mechanism of AFB is pretty well known. However, it is out of the scope of this contribution to 
present the details of these mechanisms and it is sufficient to known the following facts to understand 
the interest of tetrapyrroles in thwarting AFB action. Briefly, AFB is metabolized by cytochrome P450 
(CYP) enzymes to the exo-AFB-8,9-epoxide (AFBO), which constitutes the main metabolites of the 
reaction. (for details, see recent reviews, e.g., [77]). AFBO is highly reactive, and can further bind 
covalently to cellular macromolecules such DNA forming AFB-N7-guanine adducts. These adducts 
are chemically unstable and rapidly excreted but they are stabilized through rearranging to  
a ring-opened formamidopyramidine structure. The AFB-DNA-adducts can trigger somatic alterations 
at transcriptionally active DNA regions when not removed by DNA repair enzymes [78]. The ability of 
Chlin to form complex with carcinogens is not restricted to AFB (for a review, see [79]) as AFB could 
also bind heterocyclic amines that favour the development of colorectal adenoma [80]. Heterocyclic 
amines are for instance produced when meat is cooked at high temperature [80]. Thus, Chlin exhibits 
the property to chelate AFB yielding to the formation of chemically stable Chlin-AFB complexes, and 
those complexes are no longer absorbed by intestine and excreted with feces [81]. Moreover, 
inhibitory effects of Chlin on human CYP have been reported [82]. Based on these effects, Chlin was 
used recently in a chemointervention trial in China, resulting in a 55% reduction of the urinary  
AFB-N7-guanine adduct [83]. Shaughnessy et al. [84] proposed arguments for a protective action of 
Chl on DNA damages. The efficiency of dephytylated compounds is less than the phytylated  
ones [85]. In addition, Chlin has been reported to exhibit an anti-proliferative effect on various cancer 
cell lines [86–88]. Priyadarsini et al. [70]) reported that Chlin alterates the expression of genes coding 
for proteins involved in the transformation of normal to malignant phenotype of buccal pouch cells. 
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However, Nelson [89] reported that commercially available Chlin can have a tumor promoting effect 
and at present the Chlin content in food is regulated [55]. 
Microalgae pigments may have interest to restore drug sensitivity or reverse multi-drug resistance 
(MDR) in cancer cells, as some of them inhibit or down-regulate drug efflux pumps. For instance, a 
significant reduction of P-glycoprotein expression in drug-resistant hepatocellular carcinoma  
(R-HepG2) cells, at both transcriptional and translational levels, was observed when cells were treated 
with pheophorbide a [90]. Recently, a natural Chl of the Phaeophyceae, Chl c2, was found to trigger 
the degranulation of a rat basophilic leukemia cell line (RBL-2H3), whereas Chl a and b were unable 
to do it [91]. In addition, Chl c2 has an anti-allergic power. 
3.1.1.3. Miscellaneous 
Because of their antioxidant and anti-inflammatory activity, most microalga pigments have 
neuroprotective effects in cultures rat cerebellar neurons, and hepatoprotective effects in hepatocytes 
grown in vitro (e.g., phycocyanin, phycoerythrin [92]). Besides, some studies have demonstrated  
anti-viral and anti-fungal activities for some pigments (e.g., allophycocyanin, phycocyanin [92]). The 
physicochemical characteristics of PBS, Chl and Chl catabolites make them suitable for use as 
fluorescent probes for cellular and tissular analysis (e.g., cell sorting, cytofluorescence, flow 
cytometry, histofluorescence, binding assays, reactive oxygen species (ROS) detection, labeling of 
pathological or apoptotic cells, etc.). Phycocyanin- or phycoerythrin-coupled anti-bodies are common 
reagents available for research and medical use, in which PBS act as powerful and highly sensitive 
fluorescent probes (for reviews, see [92]). 
3.1.2. Carotenoids 
Many xanthophylls (violaxanthin, antheraxanthin, zeaxanthin, neoxanthin, lutein, loroxanthin, 
astaxanthin and canthaxanthin) can be synthesized by microalgae while others (diatoxanthin, 
diadinoxanthin and fucoxanthin) can also be derived by brown algae ([93]; Table 1). In cyanobacteria 
carotenoids are much diversified: β-carotene; echinone, synechoxanthin, myxoxanthophyll, 
canthaxanthin, zeaxanthin, isozeaxanthin, aphanizophyll, lutein, lycopene, β-cryptoxanthin and Orange 
Carotenoid Protein (OCP) can be found (Table 1). This blue-green light photoactive protein was 
described very recently; it binds the carotenoid 3′-hydroxyechinenone as its only pigment [94,95]. 
Cyanobacteria are rich sources of lycopene, and also provide higher ratios of cis/all-trans lycopene 
which is very important in increasing the bioavailability of health beneficial lycopene [96]. 
As tetrapyrroles, carotenoids are not synthesized by humans and other animals, and moreover they 
are required for their metabolism. Table 2 illustrates the health benefits obtained with carotenoids  
from phytoplankton. 
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Table 2. Bioactivities of carotenoids from microalgae and cyanobacteria. 
Pigments Bioactivities References 
Aphanizophyll Photoprotection [97–99] 
Astaxanthin 
Anti-allergic, anti-cancer, anti cardiovascular diseases 
Anti-oxidant 
Photoprotection 
[100–102] 
[100,103,104]
[38,105] 
Canthaxanthin Anti-cancer Anti-oxidant 
[106] 
[107] 
β-Carotene 
Anti-allergic 
Anti-cancer 
Anti-oxidant 
[108,109] 
[110,111] 
[112] 
β-Cryptoxanthin Anti-inflammatory Improvement of skin health 
[113] 
[114] 
Diadinoxanthin/Diatoxanthin Photoprotection [115,116] 
Fucoxanthin 
Anti-allergic 
Anti-cancer 
Anti-inflammatory 
Anti-obesity 
Anti-oxidant 
Photoprotection 
[109,117,118]
[119,120] 
[121–123] 
[124–127] 
[128,129] 
[130] 
Fucoxanthinol Anti-cancer Anti-obesity 
[131] 
[124–126] 
Lutein Anti-inflammatory Protection of eyes 
[113] 
[131–133] 
Myxoxanthophyll Anti-oxidant Photoprotection 
[134,135] 
[97–99] 
Neoxanthin Anti-cancer [134] 
Orange Carotenoid Protein Photoprotection [136–139] 
Peridin Anti-cancer [140] 
Sporopollenin Photoprotection [141] 
Synechoxanthin Anti-oxidant [142] 
Violaxanthin Anti-cancer [111,112,134]
Violeaxanthin Anti-cancer [111,112,134]
Zeaxanthin 
Anti-allergic 
Antioxidant 
Photoprotection 
[109] 
[135,143] 
[139] 
3.1.2.1. Anti-Oxidant, Anti-Inflammatory and Anti-Mutagenic Activities 
Number of works report anti-oxidant properties of microalgae and cyanobacteria [107,110,143].  
Most microalgal and cyanobacterial pigments exert strong anti-oxidant activities in vitro and  
in vivo in animal models (Table 2). It was postulated that circulating anti-oxidants also have a role  
in the prevention of cardiovascular disease: C-reactive protein and oxidized low-density  
lipoprotein-cholesterol concentrations, are inversely related to plasmatic concentrations of vitamin C, 
carotenoids and phenols [144–146]. 
Therefore, dietary anti-oxidants may be protective against the development of inflammatory 
disease. However, additional intervention trials are required with carotenoids to precise their 
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absorption, metabolism and potential as natural anti-oxidant, anti-inflammatory and anti-mutagenic 
compounds in vivo. Carotenoids have also a role in regulating gene expression and in inducing  
cell-to-cell communications [147]. 
Astaxanthin (Asta) is a nonprovitamin A found in Haematococcus pluvialis, up to 2–20 g kg−1 on a 
dry weight basis [148]. It is a powerful anti-oxidant, more effective than vitamins C and E or other 
carotenoids [149,150]. In particular, it has been reported that the anti-oxidant properties of Asta are 
about 10 times greater than those of β-carotene, lutein, zeaxanthin, canthaxanthin and over 500 greater 
than that of α-tocopherol. Thus the term “super vitamin E” has been proposed for Asta [100,103]. Asta 
has also a great potential to prevent cancer, diabetes and cardiovascular diseases [100,101]. The 
presence of the hydroxyl and keto endings on each ionone ring explains Asta unique features, such as 
the ability to be esterified [115], a higher anti-oxidant activity and a more polar configuration than 
other carotenoids [38,102,128]. Because of its anti-oxidant and membrane preservation properties, 
Asta has a considerable potential in the prevention and treatment of various chronic inflammatory 
disorders, such as cancers, rheumatoid arthritis, metabolic syndrome, diabetes, diabetic nephropathy, 
and gastrointestinal liver and neurodegenerative diseases, and could provide benefits not only for the 
cardiovascular system, but also in other inflammatory diseases. Therefore, its daily consumption is a 
practical and beneficial strategy in human health management [101]. Despite of these studies the 
molecular mechanism related to the biological activities of Asta is not yet fully understood. In a recent 
study, Sayo et al. [114] investigated whether the actions of nonprovitamin A carotenoids including 
Asta are mediated via retinoid signaling in cultured human keratinocytes. They found that β-carotene, 
β-cryptoxanthin, lutein, zeaxanthin, and Asta, upregulated HAS3 gene expression and stimulated 
hyaluronan synthesis. The results suggest that nonprovitamin A can be substituted for retinoids and 
should be considered as a potential means of improving skin health. The several examples of benefits 
brought by Asta on health have however to be verified using human trials. To our knowledge, such 
trials have been started. For instance, Djordjevic et al. [104] tested the effect of Asta supplementation 
on muscle enzymes, oxidative stress markers and antioxidant response in elite young soccer players in 
Serbia. The results suggest that soccer is associated with excessive production of ROS and oxidative 
stress, which are prevented in Asta-supplemented in young soccer players. 
Fucoxanthin (Fuco) is a brown pigment belonging to the class of xanthophylls, with anti-oxidant 
properties [128] under anoxic conditions, whereas other carotenoids have practically no quenching 
abilities, donating electrons as a part of its free-radical quenching function [129]. Fuco protects cells 
and provides other health benefits [38]: it improves cardiovascular health, blood pressure, and liver 
functions; it reduces inflammation, cholesterol and triglyceride levels [119,121,124]. Moreover, Fuco 
has anti-inflammatory effects via inhibitory effects of nitric oxide production [122,123]. 
Future clinical studies should determine the effectiveness of Asta and Fuco, not only on the 
vascular structure, but also on cartilage and joint health in at-risk patients or in those with established 
osteoarthritis [38]. 
β-Carotene isan important carotenoid because it displays a pro-vitamin A activity. Because  
animal cells cannot synthesize this molecule, it is considered as an essential compound in the human 
body [151]. 
Canthaxanthin has also anti-cancer properties [106] and a potent antioxidant. In particular, it 
inhibits the oxidation of lipids in liposomes [107]. 
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Lutein and β-cryptoxanthin may down-regulate factors involved in inflammation associated with 
osteoarthritis and rheumatoid arthritis [113]. Lutein is currently considered as effective agent for the 
prevention of a variety of human diseases. Synechoxanthin, isolated in 2008 from the cyanobacterium 
Synechococcus sp. strain PCC 7002, has exceptional strong antioxidant properties [142]. 
3.1.2.2. Anti-Cancer 
Epidemiologic studies demonstrate an inverse relationship between cancer incidence and dietary 
carotene intake or blood carotenoid levels, provided the carotene intake is not too high [140,152].  
For instance, Moreau et al. [120] works focalized to carotenoids extracts of the marine diatom 
Odontella aurita that showed an anti-proliferative effect on cultures of bronchopulmonary and 
epithelial cells when extracts were added to cell medium. Carotenoids such as astaxanthin or lycopene 
are active inducers of communication between cells at the cell-gap junctions [100,102,153]. DNA has 
receptors for specific carotenoids in controlling connexin gene transcription (connexin being a protein 
that mediates inter-cellular permeability and communication). The immune system cells need 
intercellular communication to function effectively, so they can be affected by the DNA regulating 
mechanism of carotenoids. For example, high doses of β-carotene increase the CD4 to CD8 
lymphocyte ratio [154]. MDR reversion is often observed. Microalgae pigments may have interest to 
restore drug sensitivity or reverse MDR in cancer cells, as some of them inhibit or down-regulate drug 
efflux pumps. As examples, neoxanthin increases rhodamine accumulation in MDR colon cancer  
cells [134], inhibits the P346 glycoprotein efflux pump and reverses MDR in doxorubicin-resistant 
MCF-7 cells and hmdr1-transfected L1210, at 4 and 40 μg mL−1, respectively [155]. Violaxanthin and 
violeoxanthin are effective MDR modulators in colon, at 4 and 40 μg mL−1, respectively [111,112,134]. 
3.1.2.3. Anti-Allergic 
Some experiments performed on mices demonstrated that carotenoids (α- and β-carotene) can 
reduce sharply the immunoglobulin E production. For instance, the reduction of food allergy was 
observed on animals sensitized to ovalbumine [156]. Another work reported a similar effect of  
β-carotene combined with vitamin E on splenocytes [108]. Fuco, especially, but also Asta, zeaxanthin 
and β-carotene have anti-allergic propreties; they can block the aggregation of high affinity receptor 
for immunoglobin E via inhibiting their translocation to lipid rafts [109]. Fuco anti-allergic activity 
was recently evidenced using a rodent mast cells model [117,118]. 
3.1.2.4. Anti-Obesity 
Fuco and its metabolite fucoxanthinol [135] limit the risk of obesity [124,125]. Actually, these two 
marine carotenoids inhibit lipase activity in the gastrointestinal lumen and suppress triglyceride 
absorption [126]. During normal metabolism, the body produces heat [38]: fuco affects many enzymes 
involved in fat metabolism determining an increase in the release of energy from fat [127], thus an 
increase of thermogenesis. 
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Treatment with neoxanthin significantly reduces lipid accumulation. Examination of structures and 
functions suggests that carotenoids containing an allene bond and an additional hydroxyl sustituent on 
the side group may show suppressive effects on adipocyte differentiation [157]. 
3.1.2.5. Protection against Light 
To cope with the deleterious effects of excess illumination, photosynthetic organisms have 
developed photoprotective mechanisms that dissipate the absorbed excess energy as heat from the 
antenna system. Certain bloom-forming microalgae are “sun-adapted” and have the capacity to 
synthesize sunscreen pigments [158]. In many microalgae, the cell is made more resistant to UV light 
by the accumulation in the cell wall of sporopollenin [141], a carotene-polymer absorbing UV light. 
Lutein is one of the major xanthophylls found in green microalgae. It selectively accumulates in the 
macula of the human retina, protects the eyes from oxidative stress, and acts as a filter of the blue light 
involved in macular degeneration and age-related cataract [131–133]. Asta protects against UV light; it 
is true for microalgae, animals and human beings [38,105]. Fuco inhibits tyrosinase activity, 
melanogenesis in melanoma and UVB-induced skin pigmentation by topical or oral application [130]. 
In cyanobacteria, strong blue-green (or white) light activates a soluble carotenoid protein, the OCP 
which, by interacting with the phycobilisome, increases energy dissipation in the form of heat, thereby 
decreasing the amount of energy arriving at the RCs. Consequently, OCP plays a key role in the 
photoprotective mechanism in cyanobacteria [136–139] and it is the first photoactive protein identified 
containing a carotenoid as the photoresponsive chromophore [139]. The fluorescence decrease 
associated with this energy dissipation in the antenna was called qEcya to differentiate this mechanism 
from that existing in plants. The qEcya mechanism is not the only one that protects cyanobacteria cells 
from high irradiance. Mutants lacking zeaxanthin are very sensitive to strong light, even more than 
mutants lacking the qEcya mechanism, indicating an important role of this carotenoid in 
photoprotection [139]. 
Another protein, called the Fluorescence Recovery Protein (FRP) encoded by the slr1964 gene in 
Synechocystis PCC 6803, plays a key role in dislodging the red OCP from the phycobilisome and in 
the conversion of the free red OCP to the orange, inactive, form. As a result, under low light 
conditions, the FRP mediates the recovery of the full antenna capacity by accelerating the deactivation 
of the OCP [159]. The amplitude of photoprotection depends on both OCP concentration and FRP 
concentration but also on the OCP/FRP ratio. Therefore, the synthesis of FRP and OCP is  
probably strictly regulated to accomodate both concentration and OCP/FRP ratio to the right level  
of photoprotection. 
3.2. Lipids 
Marine and freshwater microalgae are known to be characterized by a large diversity in their lipid 
and fatty acid composition. Glycerides, phospholipids (PLs) and glycolipids are major classes 
produced and stored in different subcellular compartments of microalgae such as globules, 
endoplasmic reticulum and chloroplast, respectively. The lipid composition in marine microalgae 
reveals that the major lipid classes are neutral lipids and glycolipids but also, even in a low range, the 
phospholipid class. According to this wide variety in lipid class, these microorganisms are good 
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candidates to produce these lipids for which the amounts can vary according to culture and 
environmental factors. 
Triacylglycerols (TAG) and diacylglycerols (DAG), monogalactosyldiacylglycerols (MGDG) and 
digalactosyldiacylglycerols (DGDG), and phosphatidylcholine (PC) and phosphatidylethanolamine 
(PE) are the main classes as constitutive of neutral lipids, glycolipids, and phospholipids, respectively. 
In this section will be described a non-exhaustive information concerning the use and the effects of 
these lipids in human or animal models in relation with their health benefits. 
3.2.1. Omega-3 Polyunsaturated Fatty Acids 
Omega-3 Polyunsaturated Fatty Acids (PUFA) are well known to be beneficial for human health. 
The most recognized omega-3 fatty acid source is fish oil but its quality depends on several parameters 
such as species, seasons and quality of consumed food. Moreover, the content of lipid-soluble 
pollutants in fish oil may be high because of the biomagnification of such compounds in food chains. 
Microalgae, and specifically the marine strains, are considered as more interesting alternative sources 
for omega-3 PUFA production. Indeed, they have PUFA of higher and more constant quality than the 
ones from fish because they are at the bottom of food chains. 
Among the marine strains, the prymnesophytes as Isochrysis galbana and Pavlova lutheri are rich 
sources of docosahexaenoic acid (DHA; 6%–14% total fatty acids) and eicosapentaenoic acid  
(EPA; 5%–26% of the total fatty acids [160–164], while diatoms as Phaeodactylum tricornutum or 
Odontella aurita are rich sources of EPA (26% of the total fatty acids) [160,161,165]. 
Due to its content of DHA and EPA, Isochrysis galbana was used in alloxan-induced diabetic rats. 
This microalga induced a decreased glucose, TAG and cholesterol blood levels. However, an increased 
light-density lipoprotein level and a decreased high-density lipoprotein level were observed in the 
diabetic rats, but also in the healthy ones [166]. The marine diatom Odontella aurita is the only 
microalga known to be rich in EPA and currently approved as a dietary supplement [120]. 
Omega-3 fatty acids act as important mediators of gene expression working via the peroxisome 
proliferator-activated receptors that control the expression of the genes involved in the lipid and 
glucose metabolism and adipogenesis [167]. Ethyl-EPA markedly reduced the fatty droplets in the 
liver cells of mice fed a high-fat diet, also lowering plasma levels of total cholesterol and TAG [168]. 
Kajikawa et al. [169] showed that oral administration of highly purified EPA ethyl ester improved 
hepatic fat accumulation in high fat/high sucrose diet-fed mice by suppressing the TAG synthesis 
enzymes regulated by sterol regulatory element binding protein-1 and decreased the accumulation of 
hepatic monounsaturated fatty acids produced by stearoyl-coenzyme A desaturase 1. Numerous studies 
showed biochemical functions of Chlorella, especially when administered on the presence of 
underlying disorders such as in streptozotocin induced diabetes rats [170]. Recent studies in 
hypercholesterolemic rats have shown that DHA supplementation reduced total weight gain, adiposity 
index, high-density lipoprotein (HDL)-cholesterol and glucose plasmatic concentration regardless of 
the dose and form of supplementation [171]. 
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3.2.1.1. Cardioprotective Effects 
The cardioprotective effects of the omega-3 fatty acids such as EPA and DHA has been reported 
through epidemiological studies in human and animal models but also in cell culture studies [172–175]. 
Fish oil supplements, and other sources such as microalgae provide EPA and DHA usually used for 
human diets [176,177]. Omega-3 fatty acids are known to reduce the risk of cardiovascular disease, 
through a reduction of factors involved in metabolic syndrome development, by modification of serum 
lipid profile [176]. 
3.2.1.2. Anti-Obesity 
EPA and DHA are involved in a reduction of TAG synthesis and adiposity. During obesity, the 
body mass index and waist circumference are inversely correlated with EPA and DHA intakes [178]. 
In rabbits fed with a high cholesterol diet for 10 weeks, Chlorella vulgaris, one species of Chlorella,  
showed anti-lipidemic and anti-atherosclerotic actions [176]. Cherng et al. [179] also showed that 
Chlorella pyrenoidosa has the ability to prevent dyslipidemia in rat and hamster models that were fed 
chronic high fat. 
3.2.1.3. Anti-Cholesterol 
In type 2 diabetes patients, dietary EPA and DHA have been shown to reduce TAG and very  
low-density lipoprotein-cholesterol levels and to increase the HDL-cholesterol level, in blood [180]. 
Patients with dyslipidemia have been shown to have significant decrease in blood TAG and increase in 
HDL-cholesterol after a consumption of EPA and DHA during 3 and 6 months [181]. Adan et al. [182] 
showed that EPA and DHA feeding reduces serum cholesterol and TAG levels, and decreases platelet 
aggregation in hypercholesterolemic rats. Ethyl esters of DHA extracted from microalgae have been 
reported to decrease the plasma TAG and total cholesterol levels in rats fed high-fructose diet [183]. 
Another observation has indicated that Chlorella intake can reduce cholesterol levels in patients with 
hypercholesterolemia [184]. 
3.2.1.4. Normalizing Platelet Hyper-Aggregability 
EPA and DHA also play a key role in normalizing platelet hyper-aggregability. When added to the 
diet, EPA and DHA can alter the phospholipid membrane composition of the cells, and therefore 
impact on the synthesis and action of eicosanoids, and regulate transcription factor activity and 
abundance [177]. During dyslipidemia in rats, the use of the marine diatom Odontella aurita has 
shown beneficial effects as a reduction in the risk factors for high-fat induced metabolic syndrome 
such as hyperlipidemia, platelet aggregation and oxidative stress [177]. 
3.2.2. Glycerides 
TAG are beneficial to health provided they are rich in PUFA. This is the case for instance in the 
marine dinoflagellate Crypthecodinium cohnii that can accumulate a high % of DHA (25%–60% of the 
total fatty acids) in its TAG (oil) with only trivial amounts of other PUFA [185,186]. DAG may be 
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also interessant although considered as minor constituent [187]. Several studies have been conducted 
using a DAG-oil (producted during high-temperature process), in which the 1,3-DAG isoform was the 
major component. In this case, and by comparison with a TAG rich oil, a suppression of 
hypertriglyceridemia during the post-prandial period was observed. Moreover, a decreased body fat 
mass was obtained [188–190]. In rodent models, the anti-obesity effect of DAG oil was attributed to an 
increased fatty acid beta-oxidation and to a suppression of TAG synthesis [191,192].  
3.2.3. Phospholipids 
Phospholipids are the most important storage forms of the biologically active PUFA. In marine 
sources such as fish or microalgae, the omega-3 fatty acids are usually found both in triacylgycerol 
form and as phospholipids. Many studies have reported high amounts of omega-3 fatty acids such as 
EPA and DHA in phospholipids from fish and other marine sources [193–196]. Omega-3 fatty acid 
rich PC by comparison with other PC improves disorders related with obesity. Indeed, these 
phospholipids increase the fatty acid beta-oxidation and the adiponectin levels in serum of  
obese rats [197]. 
In addition, Lemaitre-Delaunay et al. [198] have shown the potential interest of PC-DHA over 
TAG-DHA, which might favor the DHA uptake by erythrocytes and putatively by the brain, providing 
that phospholipid sources of DHA are available. Indeed, the metabolic fate of DHA differs 
substantially when ingested in TAG or PC both in terms of bioavailability in plasma and accumulation 
in target tissues. 
The intake of dietary phospholipids such as PC and PE are estimated to 3–4 g/day, which amounts 
5%–8% of total dietary lipids [199,200]. These amounts are enough to have beneficial effects on 
health, by comparison with dietary TAG. PE intake has been reported to have a cholesterol-lowering 
effect in rats in relation with fecal neutral steroid excretion [201,202]. Cholesterol liver metabolism is 
also improved by PC. Indeed, this phospholipid has protective effects on liver metabolism; it has been 
observed a decreased cholesterol level by enhancing bile cholesterol secretion, decreasing lymphatic 
cholesterol absorption and reducing fatty acid synthesis in different animal models [203,204]. Minor 
phospholipids such as phosphatidylinositol has been reported to increase the HDL-cholesterol levels in 
mammals [205–207], by mobilization of cellular sterol. 
4. Changing the Cultivation Conditions for Optimizing the Production of Bioactive Compounds 
Abiotic stresses, such as high irradiance, nutrient starvation, UV irradiation, trigger metabolic 
reorientations ending with the production of other bioactive compounds such as omega-3 fatty acids  
or carotenoids. 
4.1. Pigments 
In natural conditions, the pigment contents vary with hydrographic factors of the ocean and  
the seasons (e.g., [208]). It means that cultivated algae can produce large quantities of pigments if 
some environmental growth conditions, such as temperature, light intensity and nutrients, are 
controlled [209]. 
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4.1.1. Tetrapyrroles 
In the photosynthetic membranes, closed tetrapyrroles form complex with carotenoids. In these 
complexes, they are photoprotected from photooxidation by carotenoids [68,210]. This protection is 
absolutely required because the absolute yield of singlet oxygen formation through tetrapyrrole 
irradiation (via its triplet excited state) is between 0.3 and 0.9, depending on the type of tetrapyrrole 
and solvent conditions (reviewed by Spikes and Bommer [211]. Singlet oxygen formation triggers a 
cascade of reactions in which other ROS are formed [212], reviewed by Spikes and Bommer [211]). 
Photodynamic herbicides (reviewed by [213]) and photodynamic treatments of cancers (reviewed  
by [214,215]) are based on this mechanism. Therefore, tetrapyrrole synthesis and accumulation in 
photosynthetic cell was always strictly regulated and even for short illumination time, tetrapyrroles 
should be protected [37,216,217]. Consequently, the tetrapyrrole biosynthetic pathway will not be 
reviewed in this contribution. 
4.1.2. Carotenoids 
In microalgae, photosynthesis is efficiently performed if carotenoids are bound to peptides to form 
pigment–protein complexes in the thylakoid membrane. In algae, carotenoids function essentially as 
accessory light harvesting pigments during the light phase of photosynthesis and as agents to 
photoprotect the photosynthetic apparatus from excess light dissipation by scavenging ROS such as 
singlet oxygen and free radicals [218–220]. Carotenoids in the majority of green algae are synthesized 
and accumulate within plastids, while secondary xanthophylls (e.g., Asta in Haematococcus pluvialis) 
accumulate in the cytosol. However, these xanthophylls are synthesized in the chloroplast, but they 
accumulate in the cytosol (Figure 1). Thus xanthophylls can be found in all cellular compartments [221]). 
NADPH is required in the early steps of carotenoid biosynthesis [222]; consequently, for an efficient 
carotenoid biosynthesis, efficient light-dependent reactions of photosynthesis are needed (NADP+ 
must be photoreduced) (Figure 1). 
Most of the carotenoids of cyanobacteria are embedded in the photosynthetic membrane which is 
both, the site of their synthesis and the site of their major functions of light harvesting  
and photoprotection. Some carotenoids are exported to the periphery of the cell, especially during  
high intensity light exposure, where it may provide additional photoprotection [223,224]. Other 
carotenoid proteins may be involved in the transport of carotenoid from the photosynthetic membrane 
to the exterior. 
Control of photosynthetic gene expression and enzyme activity is coordinated by a number of 
molecular triggers including photosynthetic metabolites, hormones, Chl and carotenoid biosynthesis 
precursors, photoreceptors, stress-generated ROS, and soluble redox active compounds [225,226]. All 
known enzymes involved in carotenoid synthesis are nuclear encoded, but the carotenoid synthesis 
itself takes place in chloroplasts [222,227,228] (Figure 1). Most of xanthophylls are structural and 
functional components of the cellular photosynthetic apparatus and for this reason are considered as 
primary carotenoids essential for survival [93] whereas it is not the case for secondary carotenoids 
produced in large amounts [93,229,230]. Carotenoid content in some microalgae can be increased up 
to 140 mg g−1 biomass by manipulating environmental conditions [149]. 
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Figure 1. Scheme of the biochemical pathways leading to carotenoids and other 
terpenoids. The DOXP/MEP pathway produces the isoprenoid precursors DMAPP and 
IPP, that are required for the production of carotenoids and other chloroplast-produced 
terpenoids. Some of the intermediates of the DOXP/MEP pathway can be exported to the 
cytoplasm and used in the mevalonate pathway of terpenoid synthesis. The cytoplasmic 
mevalonate pathway does not provide IPP to the chloroplastic DOPX/MEP pathway 
neither in chloroplast nor in chromoplasts [231]. In contrast, the chloroplastic pathway 
delivers IPP to the cytoplasmic pathway, allowing the incorporation of photosynthetically fixed 
C into sterols [231]. Dashed arrows indicate the Asta biosynthetic pathway from β-carotene. 
 
CDP-ME: 4-diphosphocytidyl-2-C-methylerythritol; CDP-ME2P: 4-diphosphocytidyl-2-C-methyl-D-
erythritol-2-phosphate; CMK: CDP-ME kinase; CMS: CDP-ME synthase; DMAPP: dimethylallyl 
diphosphate; DOXP: 1-deoxy-D-xylulose 5-phosphate; DXR: DOXP reductoisomerase; DXS: DOXP 
synthase; FPP: farnesyl diphosphate; GA-3P: glyceraldehyde-3-phosphate; GGPP: geranylgeranyl 
diphosphate/pyrophosphate; GPP: geranyl diphosphate; GPPS: geranyl diphosphate synthase; HDS: HMBPP 
synthase; HMBPP: (E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate; IDI: isopentenyl/dimethylallyl 
diphosphate isomerase; IDS: IPP/DMAPP synthase; IPP: isopentenyl diphosphate; MCS : ME-cPP synthase; 
ME-cPP: 2-C-methyl-D-erythritol 2,4-cyclopyrophosphate; MEP: 2-C-methyl-D-erythritol-4-phosphate. 
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4.1.2.1. Temperature 
Increasing the temperature is a mean to change the polar to non-polar carotenoid ratio. Examples 
can be found more especially with cyanobacteria. For instance Klodawska et al. [232] demonstrated it 
on the cyanobacterium Synochocystis sp. PCC6803, for which polar to non-polar xanthophyll ratio 
increased from 25 °C to 35 °C. Another example is given by Mehnert et al. [97] who found a specific 
increase of echinenone content in the cyanobacteria Cylindrospermopsis raciborskii and Aphanizomenon 
gracile when cultivated from 10 °C to 35 °C. In both examples, the membranes of the living cells 
became more rigid with the increasing of temperature. 
4.1.2.2. Light Intensity 
Microalgae and cyanobacteria are confronted with variations of light by movements in the water 
column and emersion for coastal benthic species. For these reasons, more than terrestrial plants, 
marine microorganisms acclimate to light level and light quality by optimizing pigment content and 
composition [208,233–235]. Therefore they display a wide diversity of light harvesting pigments 
(Table 1) allowing optimal photosynthesis at different depths in seawater.  
Autotroph microorganisms sometimes experience high levels of UV-radiation, in shallow areas and 
during low tides when they are deposited on intertidal flats. To cope with high sunlight intensities, 
microalgae have developed different photoprotective mechanisms. One of these, the xanthophyll 
cycles (Figure 1), consists in the reversible conversion of violaxanthin, antheraxanthin and  
zeaxanthin in green algae and in the reversible conversion diadinoxanthin and diatoxanthin in brown 
algae [115,234,236]. Several authors have shown that UV exposure increases carotenoid content in the 
following hours. It is true for microalgae [237–239] and cyanobacteria [98,240]. In cyanobacteria, 
carotenoid glycosides play an important role in photoprotection [97]). In cyanobacteria submitted to 
high light and nitrogen deprivation, the carotenoid content can increase [241]. A high light stress alone 
leads to an increase of myxoxanthophyll and aphanizophyll, and to a decrease of β-carotene  
content [97–99]. The increase of myxoxanthophyll amount is in agreement with a coordinated activity 
of the enzymes of the myxoxanthophyll biosynthetic pathway, with no rate-limiting intermediate  
steps [99].  
Acclimation of microalgae or cyanobacteria to low irradiance intensity or blue enriched light 
increases the synthesis of specific carotenoids (e.g., fuco in phaeophyceae [196,208,241]). Generally, 
the photoprotection or the low photoacclimation leads carbon to carotenoid synthesis whereas in 
nonstressfull conditions, carbon serves mainly to growth (cell wall edification). In the marine diatom 
Haslea ostrearia, carbon fixation by β-carboxylation is almost equal to that in the C3 pathway whereas 
under low irradiation C3 fixation dominates [242]. 
4.1.2.3. Nutrients 
Nutrient starvation is generally efficient for the overproduction of carotenoids in cyanobacteria [243].  
It is also the case for microalgae. For instance, nitrogen starvation triggers β-carotene in  
Eustigmatos cf. polyphem (Eustigmatophyceae) [244] and in Dunaliella salina [245]. β-carotene can 
accumulate in lipid globules until 14 mg per liter cell volume (i.e., 2.7% of ash-free dry weight). 
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Actually, Lamers et al. [245] applied a combined high light and nitrogen stress and observed  
a β-carotene accumulation which negatively correlated with the degree of insaturation of the total fatty 
acid pool. In a frame of an optimal production of biofuels by microalgae, nitrogen starvation is often 
applied and leads at the same time to an overproduction of β-carotene. Nitrogen starvation leads to a 
modification of the photosynthetic apparatus. The linear electron flow from water to NADP+ was 
slowed down while the cyclic electron flow was increased [246]. An overproduction of β-carotene can 
also be obtained with high nitrate contents (1–3 mM) in Dunaliella salina [247,248]. 
Low nitrate level, coupled with high light intensity, was the key to high cellular accumulation of 
Asta in Haematococcus sp [249,250] or Chlorella sp [251]. Chloroplasts of H. pluvialis degenerate in 
the transition from green coccoid cells to red cyst cells during encystment. Oil droplets containing Asta 
accounted for more than 50% of the cyst cell volume [252]. 
Varying the salt concentration is an alternative to get more carotenoids. For instance,  
when grown under optimized conditions of salinity and light intensity, Dunaliella sp produces up to 
14% β-carotene [149,253,254]. The culture of the cyanobacterium Synechocystis sp. PCC 6803 in  
high-salt conditions (0.7 M NaCl) triggers the up-regulation of protective carotenoid pigments, 
especially zeaxanthin and myxoxanthophyll [255]. The presence of externally added trehalose at the 
same time of the salt stress increased even harder the carotenoid to Chl a ratio in this strain. The high 
accumulation of carotenoids in the presence of trehalose could allow a best cell protection against salt 
induced production of ROS, and thus a best cell protection against oxidative damage [255]. 
4.1.2.4. Other Stress 
As carotenoids are thought to play an important role in the protection of cellular membrane 
lipoproteins against oxidative damage by scavenging several active oxygen species, heavy metal stress 
may stimulate carotenogenesis in cyanobacteria. Actually, elevated levels of β-carotene and Asta were 
observed in the cyanobacteria Hapalosiphon fontinalis in response to chromium (VI) [256]. 
Cells of Anabaena sp. PCC 7120, a low desiccation tolerant cyanobacterium, was subjected to 
prolonged desiccation and effect of loss of water was examined on antioxidant response as well as on 
overall viability in terms of photosynthetic activity. In desiccated state, Chl a and carotenoid contents 
increased after 1 h of incubation under desiccation. The oxygen-evolving activity declined in 
desiccated cyanobacterial biomass while rehydration led to instant recovery, indicating that cells 
protect the photosynthetic machinery against desiccation [257]. As desiccation leads to oxidative 
stress, an enhanced level of carotenoids most likely facilitates quenching of ROS. 
4.2. Lipids 
4.2.1. Temperature 
The effects of temperature on growth and on lipid and fatty acid metabolism have been studied on 
several microalgae. Indeed, in natural conditions, the temperature is one of the main environmental 
factors that can influence the biology of microalgae, and thus, influencing the carbon metabolism. 
In microalga Pavlova lutheri, it has been shown that the decrease of growth temperature (from 25 to 
15 °C) has the consequence to increase the polar lipids such the betaine lipids [163]. In these 
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conditions, the levels of sulfoquinovosyldiacylglycerol and phosphatidylglycerol were increased while 
the MGDG and TAG levels were decreased. Concerning the omega-3 fatty acids, the EPA and DHA 
levels were also increased. These results are considered as an adaptative response to temperature with 
a modulation of omega-3 fatty acids incorporated into lipids involved in the membrane building. 
In the diatom Phaeodactylum tricornutum, the decrease of growth temperature (from 25 to 10 °C) 
showed that the representative fatty acids in the total fatty acids decreased proportionally by about 
30% in palmitic acid and 20% in palmitoleic acid but increased about 85% in EPA [258].  
Other species such as the Prymnesiophyte Isochrysis galbana, when cultured at temperatures from  
15 to 30 °C showed a global lipid accumulation, with a slight decrease of the neutral lipids, by 
comparison with other polar lipids. The glycosylglyceride levels were increased while no change was 
observed concerning the phosholipid classes. At 15 °C, as observed for other strain, higher levels of  
omega-3 fatty acids were obtained (α-linolenate and DHA) while the monounsaturated and saturated 
fatty acid levels were decreased [259]. Concerning the omega-3 fatty acid levels (EPA and DHA), they 
were lower at the highest temperatures [260]. The diatom Chaetoceros sp., a tropical Australian 
microalga, was studied at different growth temperatures, from 25 to 35 °C. The highest lipid 
percentage was obtained when the cells were cultured at 25 °C. Authors showed that the highest 
omega-3 fatty acid levels were slightly lower at the highest temperatures [260,261]. The same 
observations were made concerning Phaeodactylum tricornutum in which the saturated, 
monounsaturated but also the omega-6 fatty acids were increased with temperature, while the EPA 
level was decreased [262]. Lipids produced at varing temperatures can have varing biological activities 
such as antibacterial and cytotoxic activitiesas reported by Gacheva et al. [263] for the fatty acids from 
Gloeocapsa sp. 
4.2.2. Light Intensity 
Light intensity level is the major parameter involved in the microalgal metabolism, in relation with 
photosynthesis activity. Several studies have been conducted in Pavlova lutheri, a prymnesiophyte rich 
in both EPA and DHA. The proportions of PUFA, especially EPA, have been shown to be 
significantly higher under low light, and saturated fatty acids and DHA levels were significantly higher 
under high light. In this microalga, the galactolipids, a major component of chloroplast lipid 
membranes, made up approximately 54%–66% of total lipids. The highest PUFA levels, such as those 
of EPA, were predominantly found in the galactolipid fraction when the cells were grown at  
low light [264]. Using radiolabelling carbon sources as substrate, the response to light intensity was 
specific of the use of hydrogenocarbonate or acetate [265]. Indeed, it has been shown that the lipid 
synthesis, including galactolipids and phospholipids, was increased with light intensity when the 
microalgae used inorganic carbon (hydrogenocarbonate) but a less sensitivity was observed to the light 
intensity changes when acetate, as carbon source, was used. Concerning the omega-3 fatty acids, EPA 
and DHA synthesis has been shown to be lower with high light intensities with hydrogenocarbonate 
but not with acetate. These results led the authors to hypothesize the fact that Pavlova lutheri was able 
to synthesize LC-PUFA by two distinct pathways: one inside the chloroplast, depending on light 
intensity, and another one outside the chloroplast, independent of light. 
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Studies of light intensity were made with the diatom Thalassiosira pseudonana showing significant 
changes in fatty acid and lipid composition. Cells grown under moderate continuous light level showed 
high accumulation of TAG and a reduced level of polar lipids. In the diatom Skeletonema costatum, 
the highest levels of EPA are observed with the highest light levels during late exponential phase and 
during the stationary phase [266]. In Nitzschia closterium and Isochrysis zhangjiangensis,  
after a 3 day-UVA-stress period, the PUFA content increased too [239]. By opposition, in 
Nannochloropsis sp., the degree of unsaturation of fatty acids decreased with increasing irradiance, 
with a 3-fold decrease of the percentage of total omega-3 fatty acids, caused mainly by a decrease of 
EPA [267]. Dark exposure can also impact the lipid content; for instance, the dinoflagellate 
Prorocentrum minimum reduces its content of TAG and galactolipids, whereas the total content of 
phospholipids changed little (PC, PE and phosphatidylglycerol decreased; phosphatidylserine, 
phosphatidic acid and phosphatidylinositol increased) [268]. 
4.2.3. Nutrients 
Other factors such as nutrients are involved in lipid and fatty acid synthesis. A well-documented 
description has been reviewed by Guschina [269]. The effect of phosphorus-limitation has been 
studied in different species of marine algae [270]. It has been reported that phosphorus-limitation led 
to an increased lipid content in several species such Phaeodactylum tricornutum, Chaetoceros sp. and 
Pavlova lutheri, while a decreased lipid content in the green flagellates, Nannochloris atomus and 
Tetraselmis sp. was observed. The effect of nitrogen-limitation has been studied in the microalga 
Phaeodactylum tricornutum [271]. A decrease of the nitrogen concentration caused the decrease of the 
galactolipid fraction from 21% to 12%. In contrast, both neutral lipids and phospolipids increased from 
about 73% to 79% and from 6% to 8%, respectively in nitrogen starved cells. 
The effect of CO2 on the content and composition of lipid fatty acids and chloroplast lipids has been 
studied in Dunaliella salina [272]. An increase in the CO2 concentration from 2% to 10% was shown 
to increase the total fatty acid levels. Differences in the fatty acid content and composition indicated 
increased fatty acid synthesis de novo but an inhibition of their elongation and desaturation steps. This 
led to an increase in the relative content of saturated fatty acids at the highest levels of CO2. After CO2 
stress, the MGDG/DGDG ratio was increased while the ratio of omega-3/omega-6 fatty acids, was 
clearly increased in the phosphatidylglycerol class. 
Dunaliella salina is also tolerant to high salt. It has been shown that the expression of  
β-ketoacyl-coenzyme A synthase (which catalyzes the first and rate-limiting step in fatty acid 
elongation) increased in Dunaliella salina cells transferred from 0.5 to 3.5 M NaCl [273]. It has been 
suggested that the salt adaptation in this microalga induced modifications of the fatty acid composition 
of algal membranes, and lipid analysis indicated that microsomes, but not plasma membranes or 
thylakoids, from cells grown in 3.5 M NaCl contained a considerably higher ratio of 18C (mostly 
unsaturated) to 16C (mostly saturated) fatty acids compared with cells grown in 0.5 M NaCl.  
The salt-induced ketoacyl-CoA synthase, jointly with fatty aciddesaturases, was thought to play a role 
in adapting intracellular membrane compartments to function in the high internal glycerol 
concentrations used to balance the external osmotic pressure created by high salt [273]. 
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5. Role of Chloroplast and Reticulum Compartments in Lipid and Fatty Acid Synthesis in 
Marine Microalgae 
Marine microalgae can be considered as good models in lipid and fatty acid synthesis studies. 
Indeed, different works have described that in microalgae, the lipid and fatty acid metabolic pathways 
were distributed according to the location of enzymatic activities involved in their synthesis. The main 
compartments involved in lipid and fatty acid synthesis are chloroplast and endoplasmic reticulum in 
which the glycerolipid and phospholipid classes are recovered respectively. Concerning the 
phospholipid classes, their presence depends on the microalgal species. Indeed, phospholipids can be 
replaced by betaine lipids and thus gives some specificity in the concerned species. However, as for 
the phopholipids, the betaine lipids are also recovered outside the chloroplast, in the reticulum. 
In this section, we will describe the location of the different metabolic pathways by the use or data 
reported on microalgae. Moreover, and specifically in the marine microalgae, the influence of 
environmental factors on omega-3 fatty acid metabolism will be described. 
5.1. Lipid and Fatty Acid Plastid Synthesis in Microalgae 
Main reports have been conducted in plant models from which lipid trafficking pathways have been 
proposed with a difference in lipid location. Even if the lipid composition of plant cell membranes can 
vary according to environmental factors, cell type culture or development state, it is recognized that 
glycolipids such as MGDG, DGDG or sulfoquinovosyldiacylglycerol are exclusively lipid elements of 
plastidial membranes while the phospholipids have a less typical distribution. Among the phosholipid 
classes, the PC, absent from the thylakoids, are only present in the outer membrane of plasts. 
Concerning the PE and phosphatidylserine, these classes are totally absent of the plasts [120]. From 
these results, it can be suggested that the enzyme complex involved in the lipid synthesis are located in 
specific cellular compartments or that lipid transport can occur in cell to transfer lipids from one 
compartment to another one. 
It is well-recognized that the major lipid class in the chloroplast compartment is the glycolipid class 
even if phosphatidylglycerol is the main phospholipid in this subcellular fraction. Fatty acids 
incorporated into glycolipids are related with their metabolism. Indeed, according to the chain length, 
fatty acids are synthesized during a de novo plastid metabolism or are imported from the endoplasmic 
reticulum before being incorporated into the glycolipids [274]. According to the identification of the 
enzymes involved in the glycolipid synthesis in the chloroplast, and their resemblance with the 
bacterial enzymes, the plast metabolic pathways were named prokaryotic pathway while the reactions 
involved in the endoplasmic reticulum were named the eukaryotic pathway. The prokaryotic pathway 
is characterized by properties to incoporate C16 fatty acids at the sn-1 position. Some fatty acids 
synthesized in the plast compartment are exported to the endoplasmic reticulum and these are involved 
in the synthesis of lipids of non chloroplastic membranes. These fatty acids, and specifically the C18 
ones, are more incorporated into the sn-2 position, and are used to synthesize longer and more 
unsaturated fatty acids through the eukaryotic pathway [274]. 
Another example of fatty acid and lipid traffic between the endoplasmic reticulum and the 
chloroplast is that in some algal species, fatty acids incorporated into diacylglycerols of the 
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endoplasmic reticulum compartment are metabolized into the chloroplast one to produce in situ 
diacylglycerols for the formation of chloroplast galactolipids. Then, once these fatty acids are 
incorporated into structural lipids of chloroplasts, they can undergo desaturation without the need for 
deacylation-reacylation [275]. These results confirmed previous studies in which it was shown that 
MGDG-bound plamitate was desaturated into palmitoleate in the cyanobacteria Anabaena variabilis, 
without any detectable deacylation and reacylation [276]. Experiments conducted in Dunaliella salina, 
using radioisotope labeling experiments, showed that MGDG and DGDG were more associated with 
desaturation of galactolipid-bound fatty acids, in relation with desaturase enzymes located in the 
chloroplast envelope [277]. 
In the marine diatom Phaeodactylum tricornutum, it has been reported the characterization of two 
cDNAs coding for a plastidial and microsomal delta-12 desaturase. According to these results a 
compartmentalization in the synthesis of the different fatty acids have been proposed with an specific 
incorporation of EPA into the galactolipid fraction of the plastidic compartment [277]. 
In Pavlova lutheri species, two unusual compounds, diacylglyceryl carboxyhydroxymethylcholine 
(DGCC) and diacylglyceryl glucuronide (DGGA), are identified in the lipid fraction. DGCC is 
enriched in palmitate and EPA, and DGGA contained predominantly oleate, docosapentaenoic and 
docosahexaenoic (DHA) acids. Analysis of subcellular membrane fractions demonstrated an 
accumulation of these lipids together with a betaine lipid, diacylglyceryl hydroxymethyl-N,N, 
N-trimethyl-β-alanine, in non-plastid membranes [278]. Using radiolabelled acetate as precursor of 
lipid and fatty acid synthesis, the authors suggested that the betaine lipid DGCC acted as a first 
acceptor of de novo-formed or exogenous fatty acids which undergo processing and redistribution. It 
was suggested that C18 and C20 fatty acids were individually transferred from cytoplasm to 
chloroplast, allowing the synthesis of eukaryotic MGDG without import of DAG. 
In this microalga, it has been shown that it was able to synthesize long chain-polyunsaturated fatty 
acids (LC-PUFA) from radiolabelled carbon sources such as hydrogenocarbonate or acetate, by 
successive elongation and desaturation steps. Synthesis of lipids, including galactolipids and 
phospholipids/betaine lipids has also been demonstrated. According to light-dependent studies, two 
distinct enzyme pools involved in the LC-PUFA synthesis have been proposed, one light-dependent 
inside the chloroplast, and another one, light-independent and outside the chloroplast [279]. Using both 
acetate and hydrogenocarbonate, this microalga was able to synthesize LC-PUFA by successive 
desaturation and elongation steps. The use of both substrates induces different synthesized fatty acids. 
Indeed, from hydrogenocarbonate as substrate, the main synthesized fatty acids are C16 fatty acids and 
EPA, while with acetate, the main fatty acid was a C18. One hypothesis proposed by the authors was 
that the synthesis of acetyl-CoA from hydrogenocarbonate is mainly intra-chloroplastidic by 
opposition with the synthesis of acetate outside the chloroplast. Thus, fatty acids synthesized from 
chloroplastidic acetyl-CoA can be metabolized by enzymes of thylakoid such as desaturases. Using 
radiolabelled acetate as substrate, radioactivity incorporated into fatty acids is supposed to derived 
from cytosolic acetyl-CoA formed, hypothesizing a de novo fatty acids synthesis outside the 
chloroplast [279]. 
A proposed lipid synthesis pathway in the marine microalga Pavlova lutheri is reported in Figure 2. 
The role of chloroplast and endoplasmic reticulum compartments is proposed for the lipid synthesis 
and the location of omega-3 fatty acid incorporation. 
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Figure 2. Proposed lipid synthesis pathway in the marine microalgae. Role of chloroplast 
and endoplasmic reticulum compartments in lipid synthesis and location of omega-3 fatty 
acid incorporation [265,277–280]. ACP, acyl carrier protein; BL, betaine lipid; DES, 
desaturase; DAG, diacylglycerol; DAGAT, diacylglycerol acyltransferase; DGDG, 
digalactosyldiacylglycerol; DHA, docosahexaenoic acid; ELO, elongase; EPA, 
eicosapentaenoic acid; FAS, fatty acid synthase; MGDG, monogalactosyldiacylglycerol; 
PL, phospholipid; TAG, triacylglycerol; Δ-Cx, unsaturated fatty acid. 
 
5.2. Compartmentalization of EPA and DHA Synthesis 
Concerning the galactolipid synthesis and the incorporation of EPA, both prokaryotic and 
eukaryotic types have been shown to be the main end products of biosynthesis [281]. The prokaryotic 
molecular species, C20 fatty acids such as EPA and ARA were mainly incorporated into the sn-1 
position of the galactolipids, while C16 fatty acids were preferentially esterified into the sn-2 one. 
Concerning the eukaryotic species, both positions were occupied by the C20 fatty acids [281]. 
Independently, whatever the molecular species, the cytoplasmic and chloroplastic lipids were involved 
in the metabolism of galactolipids. Cytoplasmic linoleoyl-PC has been proposed to be converted into 
either arachidonyl-PC in the omega-6 pathway or into EPA-PC, which would be used to be converted 
into diacylglycerols (DAGs) moieties and then transferred to chloroplasts. In the chloroplasts, the 
DAGs have been proposed to be galactosylated to the respective monogalactosyldiacylglycerol 
(MGDG) molecular species. In the last steps, a chloroplastic delta-17 desaturation would be involved 
in the conversion of ARA-MGDG into galactolipids rich in EPA. Studies conducted with an inhibitor 
of the delta-6 desaturation involved in the chloroplastic conversion of linoleic acid into α-linolenic 
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acid and using radiolabelled carbon source (acetate) or fatty acid (linoleic acid) permit to elucidate the 
biosynthesis of EPA. These studies have confirmed the role played by the PC as substrate for the first 
step in the omega-3 pathway metabolism [282]. The PC were more involved in the desaturation of C18 
fatty acids while some species such as PE and betaine lipid (diacylglyceryl trimethylhomoserine 
DGTS) are preferential substrates for desaturation of C20 fatty acids involved in the EPA  
synthesis [283]. Moreover, these polar lipids were supposed to be imported to the chloroplastic 
compartment, from endoplasmic reticulum. The role of EPA and DGTS were suggested to be donors 
of C20-riched DAG, ARA and EPA, from which these fatty acids were incorporated into the 
galactolipid classes such as the MGDG [283]. 
In Nannochloropsis, the synthesis of EPA ouside the chloroplast has been proposed by the use of 
radiolabelled acetate and by kinetic studies in a mutant strain. In these studies, an alteration of the fatty 
acid composition of lipids was observed, in relation with the EPA synthesis [284]. In the marine green 
alga Chlorella minutissima, the betaine lipid DGTS was characterized by a very high EPA content 
representing 90% of total fatty acids. By contrast with other algae, the EPA was incorporated into the 
both sn-1 and sn-2 positions of the DGTS. Moreover, a close relationship between the DGTS and the 
PC amounts was observed [285]. In Chlorella minutissima, the DGTS level showed a fluctuation 
which was inversely correlated with the level of MGDG, the other major lipid in this alga. Moreover, 
the fatty acid composition of the latter was very similar to that of DGTS and, taken together, these 
findings also support the proposed role of DGTS as a donor of EPA for chloroplast lipids in some 
microalga species [285]. A mutant of Porphyridium cruentum, which was selected on the basis of 
impaired growth in function of temperatures, has been used to study lipid metabolism [286]. Lipid 
analysis of the mutant revealed a decreased level of EPA and of the eukaryotic molecular species of 
MGDG and an increased proportion of TAG by comparison with the wild-type. Pulse-chase labelling 
of the wild-type algae with radioactive fatty acid precursors showed an initial incorporation of the fatty 
acids into PC and TAG. In the chase period, the label of these lipids decreased with time while that of 
chloroplastic lipids, mainly MGDG, continued to increase. In the mutant, however, the labelling of 
TAG after the pulse was higher than that of the wild-type and decreased only slightly in the subsequent 
chase. It was concluded that in wild-type Porphyridium cruentum, TAG can supply acyl groups for the 
biosynthesis of eukaryotic species of MGDG [286]. 
Concerning the DHA synthesis, some microalgae as Isochrysis galbana or Pavlova lutheri 
(Haptophyta) are known to produce this fatty acid from C20 metabolism such as EPA [283]. 
According to previous studies conducted in Pavlova lutheri, it could be considered that the DHA 
synthesis and its incorporation into lipids are specific of the endoplasmic reticulum fraction with a 
preferential incorporation into the phospholipids and the betaine lipids [265,278]. Furthermore, as EPA 
is preferentially incorporated into the galactolipid fractions, these lipids being specific of 
chloroplastidic metabolism, it can be considered that after a chloroplastidic synthesis, EPA would be 
exported from this compartment into the endoplasmic reticulum in which it would be elongated and 
desaturated into DHA before being incorporated into specific polar lipids of this compartment. 
Another marine microalga, Crypthecodinium cohnii, is known to be rich in DHA without 
accumulation of other PUFAs of the omega-6 and the omega-3 series. In this microalga, the DHA level 
is about 40%–50% of the total fatty acids without intermediate substrates and products of desaturation 
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and elongation steps. This heterotrophic chloroplast-less microalga has a specific metabolism in which 
other enzyme pools and subcellular compartments are involved in PUFA synthesis [287]. 
6. Conclusion and Perspectives 
Phytoplankton is an exceptionnal source for a variety of bioactive compounds. Among them, 
pigments and lipids are recognized to have numerous positive effects on health. Very often, synergistic 
actions between these two kinds of molecules are described. Actually, most studies are done in vitro, 
so it is necessary to develop clinical tests to evaluate their ability, in vivo, to avoid some human 
diseases as well as their possible secondary effects. More, additional intervention trials are required 
with pigments to precisely determine their absorption, metabolism and potential as natural  
anti-oxidant, anti-inflammatory and anti-mutagenic compounds in vivo. 
However, phytoplankton remains largely unexplored and, until now, very few commercial 
achievements of microalgal biotechnology have emerged [288]. Also, increased harvesting of 
commercial algae can be considered beneficial for the environment, as they are photosynthetic,  
i.e., carbon dioxide-absorbing organisms, and thus their cultivation can limit greenhouse gas  
emissions [289]. Chen et al. [290] engineered strategies for simultaneous enhancement of phycocyanin 
production and CO2 fixation with Spirulina platensis. 
Microalgae are usually cultivated under light. Light is required to get more Chl [291]. However, 
some species (e.g., Chlorella protothecoides, Crypthecodinium cohnii, Schizochytrium limacinum, 
Haematococcus pluvialis) can be grown heterotrophically [292]. They are cultivated in the dark thanks 
to a carbon source replacing the more expensive traditional support of light energy. This kind of 
culture is generally restricted to small volumes of high-value products. Other microorganisms  
(e.g., Haematococcus pluvialis, Scenedesmus acutus, Chlorella vulgaris, Nannochloropsis sp.) also 
have the ability to grow mixotrophically (with a mix of different sources of carbon and energy). Via 
this technique, BioReal (Sweden) was the first company to produce and commercialize Asta  
(15 to 30 T/year) [293]. 
In this review, we have showed that different parameters can be used to increase pigment and  
lipid production, e.g., temperature, nutrient starvation, nitrogen concentration, desiccation, CO2 level, 
salt stress or metal stress. Whatever their means of production, some species are cultivated in large 
volumes and given as food supplement for their global health benefits. This is the case for  
Tetraselmis suecica, Botryococcus braunii, Neochloris oleoabundans, Isochrysis sp., Chlorella vulgaris, 
Phaeodactylum tricornutum and Odontella aurita [110,120]. When particular growth conditions are 
applied on a microalga species with the goal to optimize the production of one interesting molecule, it is 
not rare that another interesting molecule is also produced. For instance, Fernandez Sevilla et al. [294] 
succeeded in cultivating a Scenedesmus almeriensis strain rich in oils and carotenoids, and in lutein  
in particular. 
Nowadays, production of carotenoids has become one of the most successful activities in algal 
biotechnology, because of the demand for natural products, instead of being chemically synthesized, 
despite the fact that synthetic carotenoids have a lower production cost [293]. Carotenoids and 
especially β-carotene as pigments, are utilised in food and beverages, but also in aquaculture  
feed [143,148]. Some mg of β-carotene per gramme biomass can now be obtained from microalgae 
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(Isochrysis, Phaeodactylum, Chlorella sp. and Tetraselmis suecica) or cyanobacteria (Spirulina) mass 
cultures [110,151]. The estimated market size for natural β-carotene is 10–100 tonnes year−1 and its 
price is >750 € kg−1 [151,295]. Increasing the production of Asta is also an advantageous goal. 
The commercial exploitation of the natural microalgal diversity for the production of carotenoids 
and PUFA has already started up with few strains such as Chlorella vulgaris (Trebouxiophyceae), 
Dunaliella salina (Chlorophyceae), Haematococcus pluvialis (Chlorophyceae) [249,296] and 
Odontella aurita (Bacillariophyceae) [7,177]. Microalgae are specifically cultivated at an industrial 
scale for the production of high amounts in EPA and DHA. For example, Isochrysis sp. is produced by 
Innovative Aquaculture Products Ltd. (Lasqueti Island, Canada) and the diatom Odontella aurita is 
produced by BlueBiotech InT (Kollmar, Germany) and Innovalg (Bouin, France). The marine 
dinoflagellate, Crypthecodinium cohnii can produce DHA heterophically. In this way, a DHA-rich oil 
is produced by the American company Martek Biosciences Corporation [297] and commonly used in 
supplementation particularly in infant products [186]. 
Transgenic microalgae can be used as bioreactors for the production of bioactive molecules. This 
technology is very promising as it would simplify the production process and would lead to a 
significant decrease of the production costs. To date, a variety of recombinant proteins have been 
produced experimentally from the nuclear or chloroplast genome of transgenic microalgae, e.g., [298]. 
For the production of phycoerythrin, Ruiz-Ruiz [299] claims that further improvement could be 
pursued, e.g., P. cruentum biomass production could be optimized in tubular photobioreactors or  
open-ponds together with molecular biology approaches. For carotenoid production, the use of 
transgenic microorganisms is still difficult. The knowledge on carotenogenesis pathways in algae is 
only partial; several genes have been putatively identified in sequenced genomes [222,300]. However, 
engineering of high-yield algae still exits [301]. Efforts are being developed to engineer fatty acid 
biosynthesis in microalgae. A recent study shows the importance of a thorough characterization of the 
algal fatty acid synthase, including protein-protein interactions and regulation, for successful 
engineering [302]. It is clear from the genome information that most microorganisms have the 
potential to produce a far greater number of natural products than have been isolated previously [116]. 
In the future, a better knowledge on pigment and lipid pathways will be determinant to develop new 
technologies using transgenic marine microorganisms as “high-producers” of bioactive molecules. 
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